SecBot SecBot
SECBOTREPLAY Home › Report › KYMR

KYMR · Atlas Venture Fund X, L.P., a venture capital firm and early investor…

Kymera Therapeutics, Inc. · 144 filed Jun 24, 2026 at 17:30 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 24, 2026 at 17:30 ET

Atlas Venture Fund X, L.P., a venture capital firm and early investor in Kymera Therapeutics, filed a Form 144 notice of intent to sell 118,178 shares of common stock, valued at approximately $11.6 million. This follows a series of large sales by Atlas entities in June 2026, totaling hundreds of thousands of shares, consistent with a venture fund distributing to limited partners. The proposed sale represents a small fraction (0.12%) of Kymera's $9.4B market cap and is not a signal of fundamental deterioration.

  • Atlas Venture Fund X, L.P. filed a Form 144 to sell 118,178 shares of Kymera Therapeutics common stock.
  • Estimated market value of the proposed sale is $11,610,988.50.
  • Shares were acquired in a private placement on March 11, 2020.
  • Atlas entities have sold over 450,000 shares in June 2026 alone, including 243,976 shares on June 22, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access